Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McLaughlin

Showing results (461-470 of 726) with videos related to

Pageof 73
Sort By:
Cancer|August 15, 1986
The association of specific "favorable" cytogenetic abnormalities with secondary leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Brain, Behavior, & Immunity - Health|June 30, 2025
Peripheral blood transcriptomic differences predict depression status in individuals undergoing bariatric surgeryRebecca Milton, Anna P McLaughlin, Nicole Mariani, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 4, 2022
European principles of care for physiotherapy provision for persons with inherited bleeding disorders: Perspectives of physiotherapists and patientsPiet de Kleijn, G Duport, K Jansone, et al.
Journal of the National Cancer Institute|November 2, 1988
Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphomaP McLaughlin, W S Velasquez, J R Redman, et al.
Leukemia & Lymphoma|May 1, 1995
Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myelomaA H Sarris, A Majlis, M A Dimopoulos, et al.
Journal of Medicinal Chemistry|May 22, 2015
Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid ReceptorsShainnel O Eans, Michelle L Ganno, Elisa Mizrachi, et al.
British Journal of Pharmacology|May 12, 2017
Selective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in miceMariana Spetea, Shainnel O Eans, Michelle L Ganno, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 14, 2011
Management of muscle haematomas in patients with severe haemophilia in an evidence-poor worldB Sørensen, G M Benson, M Bladen, et al.
Iscience|May 30, 2023
Reprogramming of iron metabolism confers ferroptosis resistance in ECM-detached cellsJianping He, Abigail M Abikoye, Brett P McLaughlin, et al.
Seminars in Hematology|April 1, 1988
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's diseaseF Cabanillas, W S Velasquez, P McLaughlin, et al.
Pageof 73

Showing results (461-470 of 726) with videos related to

Sort By:
Pageof 73
Cancer|August 15, 1986
The association of specific "favorable" cytogenetic abnormalities with secondary leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Brain, Behavior, & Immunity - Health|June 30, 2025
Peripheral blood transcriptomic differences predict depression status in individuals undergoing bariatric surgeryRebecca Milton, Anna P McLaughlin, Nicole Mariani, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 4, 2022
European principles of care for physiotherapy provision for persons with inherited bleeding disorders: Perspectives of physiotherapists and patientsPiet de Kleijn, G Duport, K Jansone, et al.
Journal of the National Cancer Institute|November 2, 1988
Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphomaP McLaughlin, W S Velasquez, J R Redman, et al.
Leukemia & Lymphoma|May 1, 1995
Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myelomaA H Sarris, A Majlis, M A Dimopoulos, et al.
Journal of Medicinal Chemistry|May 22, 2015
Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid ReceptorsShainnel O Eans, Michelle L Ganno, Elisa Mizrachi, et al.
British Journal of Pharmacology|May 12, 2017
Selective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in miceMariana Spetea, Shainnel O Eans, Michelle L Ganno, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 14, 2011
Management of muscle haematomas in patients with severe haemophilia in an evidence-poor worldB Sørensen, G M Benson, M Bladen, et al.
Iscience|May 30, 2023
Reprogramming of iron metabolism confers ferroptosis resistance in ECM-detached cellsJianping He, Abigail M Abikoye, Brett P McLaughlin, et al.
Seminars in Hematology|April 1, 1988
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's diseaseF Cabanillas, W S Velasquez, P McLaughlin, et al.
Pageof 73